The Cleveland Clinic Foundation Center for Continuing Education
Lecturer
Leonard Calabrese, DO, John Cush, MD, Jonathan Kay, MD, R. John Looney, MD, Eamonn Molloy, MD,
Christopher T. Ritchlin, MD, E. William St. Clair, MD and Nizar N. Zein, MD
Approximate duration:
2.5 hrs.
Summary points:
In this audiovisual CME programme, a panel of rheumatology experts discuss findings from the Biologics Therapies Summitt III, including recommendations for monitoring immunocompetency in clinical trials of immunosuppressive therapies, and the risks for serious infections with biologic use.
Accreditation:
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits.
Expiration Date: September 4, 2011.
Biologics and Infections: Common and Rare
